Company intelligence / Profile preview

Advanced Life Solutions

Ownership: Private
Development stage: Preclinical

Overview

Perla® is a new organ preservation solution developed and patented by the University of Barcelona. It is currently CE mark pending and not yet approved for clinical use[1].

Therapeutic areas: Immunology
Modalities: Organ preservation solutions
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Perla®

Pre-clinical

Indications: Organ transplantation

Partnerships

University of Barcelona (patent licensor)BPILyonbiopoleLa French Care[1]

Beyond the preview

Go deeper on Advanced Life Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Life Solutions.

Explore the full profile